Semin Respir Crit Care Med 2019; 40(02): 271-277
DOI: 10.1055/s-0039-1684007
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Interstitial Pneumonia with Autoimmune Features and Undifferentiated Connective Tissue Disease

Andrea K. Chernau
1   Rocky Vista University College of Osteopathic Medicine, Parker, Colorado
,
Paolo M. Leone
2   Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy
3   Università Cattolica del Sacro Cuore, Roma, Italy
4   Interstitial Lung Disease Program, National Jewish Health, Denver, Colorado
,
Jeffrey J. Swigris
4   Interstitial Lung Disease Program, National Jewish Health, Denver, Colorado
› Author Affiliations
Further Information

Publication History

Publication Date:
28 May 2019 (online)

Abstract

In 2015, a multidisciplinary task force comprising pulmonologists, rheumatologists, pathologists, and radiologists representing the European Respiratory Society and American Thoracic Society published a diagnostic classification schema for individuals with interstitial lung disease and autoimmune features who did not meet criteria for a defined connective tissue disease. The term interstitial pneumonia with autoimmune features (IPAF) was applied. Classification criteria are often nonspecific, but up to 90% of subjects with IPAF have serological evidence for autoimmunity (particularly (+) antinuclear antibodies). Distinguishing patients with IPAF from idiopathic pulmonary disorders may be difficult. The natural history and appropriate management of IPAF have not been clarified, as data are largely limited to retrospective studies. In this review, we discuss the salient clinical, serologic, histologic, and radiographic features of IPAF and discuss an approach to management.

 
  • References

  • 1 LeRoy EC, Maricq HR, Kahaleh MB. Undifferentiated connective tissue syndromes. Arthritis Rheum 1980; 23 (03) 341-343
  • 2 LeRoy EC, Medsger Jr TA. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001; 28 (07) 1573-1576
  • 3 Mosca M, Tani C, Neri C. , et al. [Analysis of the evolution to defined connective tissue diseases of patients with “early unidifferentiated connective tissue diseases (UCTD)”]. Reumatismo 2008; 60 (01) 35-40
  • 4 Mosca M, Tani C, Bombardieri S. Undifferentiated connective tissue diseases (UCTD): a new frontier for rheumatology. Best Pract Res Clin Rheumatol 2007; 21 (06) 1011-1023
  • 5 Danieli MG, Fraticelli P, Franceschini F. , et al. Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases. Clin Exp Rheumatol 1999; 17 (05) 585-591
  • 6 Ganczarczyk L, Urowitz MB, Gladman DD. “Latent lupus”. J Rheumatol 1989; 16 (04) 475-478
  • 7 Greer JM, Panush RS. Incomplete lupus erythematosus. Arch Intern Med 1989; 149 (11) 2473-2476
  • 8 Swaak AJ, van de Brink H, Smeenk RJ. , et al; Study group on incomplete SLE and SLE with disease duration longer than 10 years. Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT). Rheumatology (Oxford) 2001; 40 (01) 89-94
  • 9 Bodolay E, Csiki Z, Szekanecz Z. , et al. Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD). Clin Exp Rheumatol 2003; 21 (03) 313-320
  • 10 Hoffman RW, Greidinger EL. Mixed connective tissue disease. Curr Opin Rheumatol 2000; 12 (05) 386-390
  • 11 Riccardi A, Irace R, Di Stefano I. , et al. Lung involvement in “stable” undifferentiated connective tissue diseases: a rheumatology perspective. Clin Rheumatol 2017; 36 (08) 1833-1837
  • 12 Nascimento ECTD, Baldi BG, Sawamura MVY, Dolhnikoff M. Morphologic aspects of interstitial pneumonia with autoimmune features. Arch Pathol Lab Med 2018; 142 (09) 1080-1089
  • 13 Kinder BW, Shariat C, Collard HR. , et al. Undifferentiated connective tissue disease-associated interstitial lung disease: changes in lung function. Hai 2010; 188 (02) 143-149
  • 14 Fischer A, West SG, Swigris JJ, Brown KK, du Bois RM. Connective tissue disease-associated interstitial lung disease: a call for clarification. Chest 2010; 138 (02) 251-256
  • 15 Fischer A, Antoniou KM, Brown KK. , et al; “ERS/ATS Task Force on Undifferentiated Forms of CTD-ILD”. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 2015; 46 (04) 976-987
  • 16 Oldham JM, Adegunsoye A, Valenzi E. , et al. Characterisation of patients with interstitial pneumonia with autoimmune features. Eur Respir J 2016; 47 (06) 1767-1775
  • 17 Ahmad K, Barba T, Gamondes D. , et al. Interstitial pneumonia with autoimmune features: clinical, radiologic, and histological characteristics and outcome in a series of 57 patients. Respir Med 2017; 123: 56-62
  • 18 Yoshimura K, Kono M, Enomoto Y. , et al. Distinctive characteristics and prognostic significance of interstitial pneumonia with autoimmune features in patients with chronic fibrosing interstitial pneumonia. Respir Med 2018; 137: 167-175
  • 19 Adegunsoye A, Oldham JM, Valenzi E. , et al. Interstitial pneumonia with autoimmune features: value of histopathology. Arch Pathol Lab Med 2017; 141 (07) 960-969
  • 20 Chartrand S, Swigris JJ, Stanchev L, Lee JS, Brown KK, Fischer A. Clinical features and natural history of interstitial pneumonia with autoimmune features: a single center experience. Respir Med 2016; 119: 150-154
  • 21 Collins BF, Spiekerman CF, Shaw MA. , et al. Idiopathic interstitial pneumonia associated with autoantibodies: a large case series followed over 1 year. Chest 2017; 152 (01) 103-112
  • 22 Ferri C, Manfredi A, Sebastiani M. , et al. Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: our interdisciplinary rheumatology-pneumology experience, and review of the literature. Autoimmun Rev 2016; 15 (01) 61-70
  • 23 Caspi D, Elkayam O, Eisinger M, Vardinon N, Yaron M, Burke M. Clinical significance of low titer anti-nuclear antibodies in early rheumatoid arthritis: implications on the presentation and long-term course of the disease. Rheumatol Int 2001; 20 (02) 43-47
  • 24 Sox Jr HC, Liang MH. The erythrocyte sedimentation rate. Guidelines for rational use. Ann Intern Med 1986; 104 (04) 515-523
  • 25 Spoorenberg A, van der Heijde D, de Klerk E. , et al. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 1999; 26 (04) 980-984
  • 26 Akçakaya MO, Yörükoğlu AG, Aydoseli A. , et al. Serum creatine phosphokinase levels as an indicator of muscle injury following lumbar disc surgery: comparison of fully endoscopic discectomy and microdiscectomy. Clin Neurol Neurosurg 2016; 145: 74-78
  • 27 Damoiseaux J, Csernok E, Rasmussen N. , et al. Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays. Ann Rheum Dis 2017; 76 (04) 647-653
  • 28 Radice A, Sinico RA. Antineutrophil cytoplasmic antibodies (ANCA). Autoimmunity 2005; 38 (01) 93-103
  • 29 van den Hoogen F, Khanna D, Fransen J. , et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 2013; 65 (11) 2737-2747
  • 30 Steen VD. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 2005; 35 (01) 35-42
  • 31 Chudwin DS, Ammann AJ, Cowan MJ, Wara DW. Significance of a positive antinuclear antibody test in a pediatric population. Am J Dis Child 1983; 137 (11) 1103-1106
  • 32 Dellavance A, Viana VS, Leon EP, Bonfa ES, Andrade LE, Leser PG. The clinical spectrum of antinuclear antibodies associated with the nuclear dense fine speckled immunofluorescence pattern. J Rheumatol 2005; 32 (11) 2144-2149
  • 33 Hilário MO, Len CA, Roja SC, Terreri MT, Almeida G, Andrade LE. Frequency of antinuclear antibodies in healthy children and adolescents. Clin Pediatr (Phila) 2004; 43 (07) 637-642
  • 34 Solomon DH, Kavanaugh AJ, Schur PH. ; American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 2002; 47 (04) 434-444
  • 35 Sambataro G, Torrisi SE, Vancheri A. , et al. Interstitial Pneumonia with Autoimmune Features (IPAF): a single center prospective experience. Eur Respir J 2018; 52: PA2968
  • 36 Lynch DA, Travis WD, Müller NL. , et al. Idiopathic interstitial pneumonias: CT features. Radiology 2005; 236 (01) 10-21
  • 37 Travis WD, Costabel U, Hansell DM. , et al; ATS/ERS Committee on Idiopathic Interstitial Pneumonias. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013; 188 (06) 733-748
  • 38 Ito Y, Arita M, Kumagai S. , et al. Serological and morphological prognostic factors in patients with interstitial pneumonia with autoimmune features. BMC Pulm Med 2017; 17 (01) 111
  • 39 Kono M, Nakamura Y, Enomoto N. , et al. Usual interstitial pneumonia preceding collagen vascular disease: a retrospective case control study of patients initially diagnosed with idiopathic pulmonary fibrosis. PLoS One 2014; 9 (04) e94775
  • 40 Churg A, Wright JL, Ryerson CJ. Pathologic separation of chronic hypersensitivity pneumonitis from fibrotic connective tissue disease-associated interstitial lung disease. Am J Surg Pathol 2017; 41 (10) 1403-1409
  • 41 de Lauretis A, Veeraraghavan S, Renzoni E. Review series: aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?. Chron Respir Dis 2011; 8 (01) 53-82
  • 42 Chung JH, Montner SM, Adegunsoye A. , et al. CT findings, radiologic-pathologic correlation, and imaging predictors of survival for patients with interstitial pneumonia with autoimmune features. AJR Am J Roentgenol 2017; 208 (06) 1229-1236
  • 43 Collins B, Raghu G. Interstitial pneumonia with autoimmune features: the new consensus-based definition for this cohort of patients should be broadened. Eur Respir J 2016; 47 (04) 1293-1295
  • 44 Strek ME, Oldham JM, Adegunsoye A, Vij R. A call for uniformity in implementing the IPAF (interstitial pneumonia with autoimmune features) criteria. Eur Respir J 2016; 48 (06) 1813-1814
  • 45 McCoy SS, Mukadam Z, Meyer KC. , et al. Mycophenolate therapy in interstitial pneumonia with autoimmune features: a cohort study. Ther Clin Risk Manag 2018; 14: 2171-2181
  • 46 Wilfong EM, Lentz RJ, Guttentag A. , et al. Interstitial pneumonia with autoimmune features: an emerging challenge at the intersection of rheumatology and pulmonology. Arthritis Rheumatol 2018; 70 (12) 1901-1913
  • 47 Dai J, Wang L, Yan X. , et al. Clinical features, risk factors, and outcomes of patients with interstitial pneumonia with autoimmune features: a population-based study. Clin Rheumatol 2018; 37 (08) 2125-2132